Search

Author/Creator D'Sa, S.

3. P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY. (23rd June 2022)

Authors:
Owen, R.; McCarthy, H.; Rule, S.; D'Sa, S.; Thomas, S.; Tournilhac, O.; Forconi, F.; José Kersten, M.; Luigi Zinzani, P.; Iyengar, S.; Kothari, J.; Minnema, M.; Kastritis, E.; Cheson, B.; Walter, H.; Greewald, D.; Calvo, R.; Wun, C.-C.; Furman, R.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1020
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P1149: THE EVOLVING STATE OF PLAY IN 1000 PATIENTS WITH WALDENSTRÖM'S MACROGLOBULINAEMIA IN THE UNITED KINGDOM (UK): A REAL-WORLD DATA ANALYSIS FROM THE WMUK RORY MORRISON REGISTRY PROJECT. (23rd June 2022)

Authors:
Uppal, E.; Otamas, A.; Khwaja, J.; McCarthy, H.; Kothari, J.; Rismani, A.; El-Sharkawi, D.; Kyriakou, C.; D'Sa, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1036
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P1159: A MULTICENTER, INTERNATIONAL COLLABORATIVE STUDY EVALUATING FRONTLINE THERAPY WITH BENDAMUSTINE RITUXIMAB FOR WALDENSTRÖM MACROGLOBULINEMIA. (23rd June 2022)

Authors:
Zanwar, S.; Abeykoon, J.; Castillo, J.; Durot, E.; Kastritis, E.; Uppal, E.; Morel, P.; Tawfiq, R.; Montes, L.; Paludo, J.; Sarosiek, S.; Kumar, S.; Ogunbiyi, O.; Cornillet-Lefebvre, P.; Kyle, R.; Delmer, A.; Gertz, M.; Dimopoulos, M.; Ansell, S.; Treon, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1046
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM). (23rd June 2022)

Authors:
Dimopoulos, M.; Opat, S.; D'Sa, S.; Jurczak, W.; Lee, H.-P.; Cull, G.; Owen, R. G.; Marlton, P.; Wahlin, B. E.; Garcia-Sanz, R.; McCarthy, H.; Mulligan, S.; Tedeschi, A.; Castillo, J. J.; Czyz, J.; Fernandez De Larrea Rodriguez, C.; Belada, D.; Libby, E.; Matous, J.; Motta, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1048
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK WASHOUT PERIOD IN PHASE 3 CARDINAL STUDY (NCT03347396). (23rd June 2022)

Authors:
Röth, A.; Barcellini, W.; D'Sa, S.; Miyakawa, Y.; Broome, C. M.; Michel, M.; Kuter, D. J.; Jilma, B.; Tvedt, T. H. A.; Weitz, I. C.; Sourdille, T.; Wang, J.; Vagge, D. S.; Kralova, K.; Shafer, F.; Wardecki, M.; Lee, M.; Berentsen, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1419
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. S285: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 2-YEAR FOLLOW-UP FROM THE CARDINAL STUDY. (23rd June 2022)

Authors:
Röth, A.; Barcellini, W.; D'Sa, S.; Miyakawa, Y.; Broome, C. M.; Michel, M.; Kuter, D. J.; Jilma, B.; Tvedt, T. H. A.; Weitz, I. C.; Sourdille, T.; Wang, J.; Vagge, D. S.; Kralova, K.; Shafer, F.; Wardecki, M.; Lee, M.; Berentsen, S.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
186
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗